Correlation Between In8bio and Elevation Oncology
Can any of the company-specific risk be diversified away by investing in both In8bio and Elevation Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining In8bio and Elevation Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between In8bio Inc and Elevation Oncology, you can compare the effects of market volatilities on In8bio and Elevation Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in In8bio with a short position of Elevation Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of In8bio and Elevation Oncology.
Diversification Opportunities for In8bio and Elevation Oncology
0.79 | Correlation Coefficient |
Poor diversification
The 3 months correlation between In8bio and Elevation is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding In8bio Inc and Elevation Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elevation Oncology and In8bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on In8bio Inc are associated (or correlated) with Elevation Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elevation Oncology has no effect on the direction of In8bio i.e., In8bio and Elevation Oncology go up and down completely randomly.
Pair Corralation between In8bio and Elevation Oncology
Given the investment horizon of 90 days In8bio is expected to generate 1.3 times less return on investment than Elevation Oncology. In addition to that, In8bio is 1.24 times more volatile than Elevation Oncology. It trades about 0.08 of its total potential returns per unit of risk. Elevation Oncology is currently generating about 0.13 per unit of volatility. If you would invest 57.00 in Elevation Oncology on September 1, 2024 and sell it today you would earn a total of 7.00 from holding Elevation Oncology or generate 12.28% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
In8bio Inc vs. Elevation Oncology
Performance |
| Timeline |
| In8bio Inc |
| Elevation Oncology |
In8bio and Elevation Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with In8bio and Elevation Oncology
The main advantage of trading using opposite In8bio and Elevation Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if In8bio position performs unexpectedly, Elevation Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elevation Oncology will offset losses from the drop in Elevation Oncology's long position.| In8bio vs. Tff Pharmaceuticals | In8bio vs. Eliem Therapeutics | In8bio vs. Inhibrx | In8bio vs. Enliven Therapeutics |
| Elevation Oncology vs. Tff Pharmaceuticals | Elevation Oncology vs. Eliem Therapeutics | Elevation Oncology vs. Inhibrx | Elevation Oncology vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |